08.15.23 -- Should My Biotech Startup Buy Or Produce The Proteins We Use?

It is important to consider several factors in the overall development approach during the early phases in order to de-risk late-phase development.

Throughout the pandemic, painkiller and sedative demands have spiked. Drug manufacturers and CDMOs have become critical in efforts to stabilize the supply of Bupivacaine HCl and other essential drugs.

Innovative technologies are necessary to improve the success rate of new drug candidates and push novel therapies to market. Recent advances in nanoparticle engineering technology promise to accomplish this.

David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

Sartorius research fellow, Christoph Zehe, walks us through the evolution of Cellca GmbH, a CLD service that began as a small startup and has become one of the leading technologies on the market.